Latest Insider Transactions at Staar Surgical CO (STAA)
This section provides a real-time view of insider transactions for Staar Surgical CO (STAA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STAAR SURGICAL CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STAAR SURGICAL CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 03
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
520
+0.01%
|
$18,720
$36.06 P/Share
|
|
Nov 02
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Nov 02
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
144,027
+0.75%
|
$5,040,945
$35.83 P/Share
|
|
Oct 06
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Oct 06
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
75,299
+0.79%
|
$2,786,063
$37.62 P/Share
|
|
Oct 05
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Oct 05
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
97,474
+1.03%
|
$3,606,538
$37.92 P/Share
|
|
Oct 04
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Oct 04
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
32,523
+0.35%
|
$1,203,351
$37.93 P/Share
|
|
Sep 29
2023
|
Aimee S Weisner |
BUY
Grant, award, or other acquisition
|
Direct |
497
+7.75%
|
$19,880
$40.18 P/Share
|
|
Sep 29
2023
|
Stephen C Farrell |
BUY
Grant, award, or other acquisition
|
Direct |
715
+7.37%
|
$28,600
$40.18 P/Share
|
|
Sep 29
2023
|
Gilbert H Kliman Director |
BUY
Grant, award, or other acquisition
|
Direct |
435
+4.13%
|
$17,400
$40.18 P/Share
|
|
Sep 21
2023
|
Elizabeth Yeu Lin |
BUY
Open market or private purchase
|
Direct |
2,500
+46.69%
|
$100,000
$40.0 P/Share
|
|
Sep 21
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 21
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
154,814
+1.64%
|
$6,037,746
$39.62 P/Share
|
|
Sep 20
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 20
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
132,079
+1.43%
|
$5,283,160
$40.67 P/Share
|
|
Sep 19
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 19
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,490
+0.05%
|
$179,600
$40.89 P/Share
|
|
Sep 07
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 07
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
60,874
+0.67%
|
$2,495,834
$41.26 P/Share
|
|
Sep 06
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 06
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
108,944
+1.21%
|
$4,466,704
$41.43 P/Share
|
|
Sep 05
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 05
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
20,144
+0.23%
|
$825,904
$41.87 P/Share
|
|
Aug 10
2023
|
Patrick F. Williams Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,539
-5.59%
|
$111,716
$44.1 P/Share
|
|
Aug 10
2023
|
Patrick F. Williams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,122
+10.14%
|
-
|
|
Aug 07
2023
|
Aimee S Weisner |
BUY
Open market or private purchase
|
Direct |
2,000
+26.97%
|
$96,000
$48.72 P/Share
|
|
Jun 15
2023
|
Stephen C Farrell |
BUY
Exercise of conversion of derivative security
|
Direct |
1,709
+17.12%
|
-
|
|
Jun 15
2023
|
Thomas G Frinzi President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
501
-0.54%
|
$26,052
$52.67 P/Share
|
|
Jun 15
2023
|
K Peony Yu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,709
+38.02%
|
-
|
|
Jun 15
2023
|
Aimee S Weisner |
BUY
Exercise of conversion of derivative security
|
Direct |
3,417
+50.0%
|
-
|
|
Jun 15
2023
|
Gilbert H Kliman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,417
+26.14%
|
-
|
|
Jun 06
2023
|
Patrick F. Williams Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,987
-4.19%
|
$107,298
$54.79 P/Share
|
|
Jun 06
2023
|
Patrick F. Williams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,121
+9.75%
|
-
|
|
May 08
2023
|
Warren Foust Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,331
+50.0%
|
-
|
|
May 08
2023
|
Magda Michna Chief Clinical, Regulatory, |
BUY
Exercise of conversion of derivative security
|
Direct |
14,047
+50.0%
|
-
|
|
Mar 20
2023
|
Scott D Barnes Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
911
-2.15%
|
$56,482
$62.07 P/Share
|
|
Mar 20
2023
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
797
-1.83%
|
$49,414
$62.07 P/Share
|
|
Mar 20
2023
|
Samuel J Gesten Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-2.0%
|
$55,304
$62.07 P/Share
|
|
Mar 20
2023
|
Keith Holliday Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
907
-3.12%
|
$56,234
$62.07 P/Share
|
|
Mar 17
2023
|
Keith Holliday Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
823
-2.89%
|
$50,203
$61.97 P/Share
|
|
Mar 10
2023
|
Scott D Barnes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,555
+20.55%
|
-
|
|
Mar 10
2023
|
Scott D Barnes Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
285
-0.93%
|
$15,960
$56.63 P/Share
|
|
Mar 10
2023
|
Robert Studholme Senior VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
8,859
+21.69%
|
-
|
|
Mar 10
2023
|
Patrick F. Williams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,184
+21.06%
|
-
|
|
Mar 10
2023
|
Patrick F. Williams Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
289
-0.86%
|
$16,184
$56.63 P/Share
|
|
Mar 10
2023
|
Keith Holliday Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,192
+26.37%
|
-
|
|
Mar 10
2023
|
Keith Holliday Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-1.53%
|
$15,904
$56.63 P/Share
|
|
Mar 10
2023
|
Samuel J Gesten Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,531
+18.07%
|
-
|